Akcea and Ionis Announce Closing of Licensing Agreement with Pfizer Inc. for Investigative Antisense Therapy AKCEA-ANGPTL3-L(Rx)

Frank Burrell
Scientific Storytelling

Amy Giles
Increasing Engagement

Joey Cohen
Medication Adherence

Matthew Durham
Omnidynamic Marketing

Pat Purcell
Meeting Engagement

David Linetsky
Point-of-Care Marketing

Matt Turner
Patient Affordability

Brenda Snow
Authentic Patient Voice

Stacey Gandler
Brand Nourishment

Daniel Sontupe
Market Access

Bud Bilanich
Success Coach

Suma Ramadas, PhD
Medical Affairs

Paul Theisen
Patient Acquisition

Liz Kane
Impactful Strategy